Philadelphia (Ph') chromosome-positive clonogenic progenitors usually disappear within 4 t o 6 weeks in long-term cultures established from the marrow of patients with chronic myeloid leukemia (CML). In contrast, coexisting chromosomally normal hematopoietic cells are relatively well maintained. Thus, even though normal cells are initially undetectable, they may become the predominant population. Recently, we have begun t o explore the potential of such cultures as a strategy for preparing CML marrow for autografting, and based on cytogenetic studies of the differential kinetics of Ph'-positive and Phl-negative clonogenic cells, have chosen a 10-day period in culture t o obtain maximal numbers of selectively enriched normal stem cells. Here we present the results of molecular analyses of the cells regenerated in vivo for the initial three CML patients t o be treated using this approach by comparison with the differentiated cells generated by continued maintenance of an aliquot of the autograft in vitro (using a H E PHILADELPHIA (Phl) chromosome is the hall-T mark of chronic myeloid leukemia (CML), a clonal myeloproliferative malignancy believed to originate in a pluripotent hematopoietic cell.' Molecular studies have identified a small region on chromosome 22, called the breakpoint cluster region (BCR), which is broken and rejoined to the c-ABL protooncogene, normally located a t the distal end of the long arm of chromosome 9.2-4 This rejoining results in the formation of the hybrid BCR-ABL gene and the synthesis of an abnormal gene product with tyrosine kinase activityss6 analogous to that exhibited by the oncogenic murine V-ABL gene product.' Using appropriate DNA probes, it is now routinely possible to detect the presence of nondividing
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0 I990 by The American Society of Hematology. Ph'-positive cells using Southern or polymerase chain reaction (PCR) technique^?^ thereby increasing accessibility of the neoplastic clone to studies beyond those dependent on cytogenetic analysis (which are restricted to proliferating cell populations). Molecular studies have thus facilitated assessment of treatment response in C M L in a variety of settings, in particular to demonstrate persistence of residual disease after suppression of the neoplastic clone by interferon" or intensive therapy supported by syngeneic or allogeneic bone marrow transplantation." Such studies have also made it possible to analyze various purified subpopulations of hematopoietic cells. These have helped to establish a lack of correlation between the particular site of the breakpoint within the BCR-1 gene and the involvement of lymphoid and/or myeloid cells in the neoplastic clone.'* In this report we show how molecular studies may be useful to assess the hematopoietic stem cell population present in 10-day culture-purged C M L marrow autografts13 based on the demonstration of the disappearance of clonal and BCR-positive cells, and the reappearance of nonclonal and BCR-negative cells after further maintenance of the cells in vitro, or in vivo following transplantation of the cultured autograft.
MATERIALS AND METHODS
Patient samples. All marrow and blood samples in this study were obtained with informed consent from the first three CML patients entered into a clinical trial developed in Vancouver. This trial was designed to evaluate the potential of cultured marrow autografts to allow hematologic recovery following myeloablative therapy and has been described previously." A blood sample was obtained from each patient before harvesting the marrow used for autografting, and then periodically after transplantation as part of the routine follow-up procedure. Light density (< 1.077 g/cm3) blood mononuclear cells were separated from the red blood cells (RBCs) and granulocytes by density gradient centrifugation on Ficoll-Hypaque, and a greater than 95% pure granulocyte fraction then recovered from the pellet by lysis of the RBCs with NH,CI-TrisHCl.I4 Bone marrow samples were collected in preservative-free sterile heparin and then divided in aliquots as required for initiation of colony assays or long-term cultures, for cryopreservation in dimethyl sulfoxide (DMSO), and for DNA extraction following washing in phosphate-buffered saline (PBS) and lysis of contaminating RBCs.
The procedure for initiating, maintaining, and harvesting cells for autografting from long-term marrow cultures was based on that used in our laboratory for many years," with the minor modification that all handling of the cells or medium for the first 10 days was e1imi11ated.l~ Most of the cultured cells were then harvested and used for autografting as previously described," although a small number of sample cultures were maintained for up to 8 weeks and periodically analyzed for clonogenic cell ~0ntent.I~
In the case of unique patient no. (UPN) 248, long-term marrow cultures were also set up with a thawed aliquot of cryopreserved marrow from the same harvest used to initiate cultures for autografting. The recovery of viable cells (based on 1% nigrosin dye exclusion) after thawing using DNAaseI6 was 40%. These viable cells, lo', were then inoculated into each of eight 75-cm2 flasks containing 30 mL of standard long-term culture medium." These flasks were maintained for the first 4 weeks with weekly half medium changes. All of the medium containing the nonadherent cells was then removed from each flask and the cultures refed with the same medium (30 mL/flask), but containing 30% fetal calf serum (FCS) rather than 12.5% FCS and 12.5% horse serum, and to which 10% medium from confluent 5637 cell cultures (obtained from the American Type Tissue Collection, Rockville, MD) was also added. This modified feeding procedure was repeated at weekly intervals until termination of the experiment at week 8.
DNA extractions, digestions, and Southern analyses were as previously described." Dilution of pretransplant CML marrow DNA with normal human DNA showed a linear relationship between the proportion of CML DNA run in each lane and the intensity of the rearranged BCR-gene band measured densitometrically over a range of 2% to 90% (data not shown), thus validating the use of Southern analysis to provide a quantitative measure of the proportion of BCR-positive cells in test samples. Operational criteria used to infer monoclonality, oligoclonality, and polyclonality from methylation-sensitive changes in phosphoglycerate kinase (PGK) band intensities were as defined by VogeIstein et a1."
Cultures. Table 1 summarizes the clinical information on the three CML patients studied. A more detailed presentation of the treatment, and clinical and laboratory findings on these patients has been published previo~s1y.l~ All had Ph'-positive CML and were in a first, second, or third chronic phase at the time of autografting. Southern analyses of BamH 1 -digested DNA from pretransplant samples of marrow and blood cells showed unique rearrangements of the BCR-1 gene in each patient (Fig 1 through 3 and Table 2 ). It should be noted that direct metaphase preparations of pretreatment marrow samples showed exclusively (Fig 1) or predominantly (Figs 2 and 3B) Phl-positive metaphases consistent with clonal dominance of the neoplastic clone in the most terminal compartments of all three patients studied, despite the penetration into the clonogenic compartments of significant numbers of Phl-negative cells in UPN 248 ( Fig  3A) . The BCR data for pretransplant granulocyte and marrow samples are also consistent with this finding.
Molecular studies.

RESULTS
Patients.
In one patient (UPN 248), the presence of a polymorphic
Bgl I site in one of her X-linked PGK genes also made it possible to undertake clonality studies." Southern analysis of DNA from pretransplant blood and marrow samples from this patient after sequential digestion with EcoRI, Bgl 11, Bgl I, and then Hpa 11, showed a pattern typical of a monoclonal cell population (Fig 4) . Neither of the other two patients was suitable for clonality studies because of homozygosity at both the hypoxanthine phosphoribosyl transferase (HPRT) and PGK loci (data not shown). Cytogenetic studies of erythroid and granulopoietic colonies produced by progenitors harvested from the long-term marrow cultures established from all three patients indicated that after 4 to 6 weeks Phl-positive clonogenic cells had declined to very low levels, but that Phl-negative clonogenic cells were readily detectable." Because cytogenetic analyses tend to be biased towards the selection of larger colonies containing at least 500 immature cells (to ensure the presence of some metaphase cells), it was of interest to investigate the pattern of population changes demonstrated by a less selective, but nevertheless quantitative technique, that could be applied to all hematopoietic cells in the culture, eg, by Southern analysis of extracted DNA. Because one, but only one, of the patients (UPN 248) offered the opportunity to assess changes in BCR-positivity and clonality simultaneously, it was of greatest interest to analyze the cells in cultures established with marrow from this individual. However, to undertake such studies, it was important to identify a practical procedure that would allow us to obtain appropriate samples of cultured cells.
In established (>4 weeks old) long-term cultures initiated with either normal or CML marrow, usually less than 20% of all the cells present are in the nonadherent fraction. Conversely, the adherent layer, even if incomplete as is often the case in cultures initiated with CML marrow, usually contains more than 80% of all the ce present. However, a significant proportion of these are stromal cells of nonhematopoietic On the other hand, it has been shown Analyses of cultured marrow cells. For that the nonadherent fraction, although smaller, consists almost exclusively of terminally differentiating granulopoietic cells that are continuously released as a result of the proliferative activity of more primitive hematopoietic cells that remain in the adherent layer.".".?' Thus, assessment of the nonadherent cell fraction might offer a strategy for assessing the genotype of hematopoietic cells active in the adherent layer I to 2 weeks previously. In preliminary experiments we found that the production, and release of hematopoietic cells into the nonadherent fraction appeared to be enhanced when weswitched the feeding procedure after 4 weeks to a complete. rather than a half, medium change and altered its composition to resemble more closely that usad to stimulate terminal granulopoiesis in methylcellulose assays containing a source of granulopoietic stimulating factors (see Materials (Fig 3A) .
DNA extracted from these cells also showed a monoclonal undetectable thereafter (Fig 3A) . BCR-positive cells w m also not detectable in the adherent layer after 5 to 8 weeks (data not shown). Clonality studies showed a concomitant emergence of a second PGK band in Southem blots of Hpal Idigested samples of her nonadherent cells. indicating the emergence of new hematopoietic clones in her cultures within 5 weeks (Fig 4) . This pattern continued for all subuquent samples (data not shown).
Results for each patient are shown respectively in Figs I , 2.3B. and 4. and are summarized in Table 2 . Twenty-cight days after the autograft when patient UPN 208 had largely regenerated her hematopoietic system and the peripheral granulocyte count had already recovered to 2.2 x 1O9/L.'' these cells did not Analyses of posttransplant samples. For include detectable (ie, >2%) BCR-positive cells (Fig I) . However, a subsequent sample taken approximately 3 months after autografting showed the reappearance of a minor (-5%) BCR-positive population. which contained the same rearrangement Seen before autografting and which remained detectable at about the same low level for another 8 months. Cytogenetic data obtained during the first year from either direct marrow preparations or colonies derived from marrow or peripheral blood progenitors gave the same picture, although given the size of the BCR-positive population that transiently reappeared 3 months after transplantation. it was not always possible to obtain sufficient metaphases to detect its presence." Becauseof the persistenceof Ph'-positive/BCRpositive cells in this patient for another 9 months. she was started on treatment with a- interferon (a-IFN) . The BCRpositive population then disappeared and all subsequently analyzed samples up to 2 years after autografting remained BCR-negative (Table 2 ). Cytogeneticdata during this period also showed the disappearance of Phl-positive cells (Kalousek DK. Barnett MJ. F~v e s CJ. Eaves AC: unpublished findings.
1990).
In UPN 232. hematopoietic recovery was slower; neverthe- For personal use only. on August 30, 2017. by guest www.bloodjournal.org From less, by day 26 after autografting the granulocyte count was a t 0.6 x 109/L.13 As shown in Fig 2, Southern analysis of granulocytes obtained a t this time showed that the original BCR-positive clone had been largely, but not completely, replaced by BCR-negative cells. This replacement was confirmed by cytogenetic studies of direct metaphases in a marrow sample obtained 3 weeks later (day +46)13 and by repeat Southern analysis of the peripheral blood granulocytes sampled on day +57. By day +77, a marked increase in the abnormal BCR band had become apparent in a Southern blot of DNA from the granulocytes in her circulation. A marrow sample obtained 5 days later was heavily infiltrated with lymphoblasts and a high proportion of proliferating cells with a duplicated Ph' chromosome. 13 No further follow-up on this patient was possible as she succumbed to this third and final recurrence of blast phase disease.
The last patient (UPN 248) also showed early evidence of hematologic recovery after autografting, but could only be studied for a limited period because she developed overwhelming therapy-related toxi~ity.'~ Only two samples of circulating granulocytes were available for DNA studies and these were obtained 24 and 27 days after autografting, at which time her peripheral granulocyte count was 1.2 x 109/L. In neither of these preparations were BCR-positive cells detected (Fig 3B and Table 2 ). Because clonality studies (by analysis of the methylation status of the PGK gene) were also possible in this patient, both posttransplant granulocyte DNA preparations were also evaluated in this way. As illustrated in Fig 4, the typical monoclonal pattern exhibited by this patient's pretransplant marrow and granulocytes was replaced in the posttransplant samples by a pattern indicative of the presence of new clones of hematopoietic cells.
DISCUSSION
The primary purpose of this study was to use molecular techniques to evaluate and compare the clonality status of cells generated both in vitro and in vivo from precursors present in 10-day-old cultures of C M L marrow. A major advantage of molecular techniques is their applicability to nondividing as well as dividing cell populations. Moreover, using methylation-sensitive analysis of certain X-linked genes, it is possible (in informative subjects) to examine the clonality of cell populations by a method that is independent of BCR gene rearrangement measurements. In this study, both of these approaches were applied to the assessment of relatively pure populations of mature hematopoietic cells (primarily granulocytes) separated from posttransplant peripheral blood samples or harvested as the nonadherent fraction of 5-to 8-week-old long-term marrow cultures.
Information obtained from analyses of these cells was then used to assign genotypes to their precursors present in the suspension of cells harvested from the 10-day-old cultures used for autografting. In every case studied, both in vitro and in vivo, BCR data confirmed and/or extended results obtained by cytogenetic analyses13 (and more recent follow-up data on patient UPN 208). More interestingly, in the one patient where clonality studies could also be undertaken, reappearance of BCR-negative hematopoiesis both in vitro and in vivo was paralleled by the emergence of new clones of differentiating granulocytes.
This result brings the number of patients whose Phlnegative (BCR-negative) hematopoietic cells appearing after several weeks in culture could be subjected to an independent analysis of clonality status to a total of three. Interestingly, in each the marker used to determine clonality has been different. The first such patient studied was a cytogenetic (Turner's syndrome) mosaic,*' the second a G6PD heterozygote,26 and the third, described here, heterozygous for a Bgl I polymorphism in the X-linked PGK gene. Only in the case described here was it possible to document complete disappearance of Ph'-positive (and BCR-positive) cells concurrent with the appearance of new clones of normal cells. The present studies also now provide evidence of the production of nonclonal, Phl-negative (BCR-negative) cells over a similar time frame in vivo (ie, within the first month after transplanting 10-day cultured cells). These findings are important because they highlight the possibility that placing human marrow under conditions used conventionally to initiate long-term cultures may allow preservation for a t least 10 days of cells with in vivo reconstituting potential. Such knowledge may be critical to optimizing the design of future therapies involving transplantation of marrow that is to be manipulated or activated in vitro.
